Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Nevzorova (Vladivostok, Russian Federation), E. Gilifanov (Vladivostok, Russian Federation), I. Martynenko (Vladivostok, Russian Federation), D. Pavlus (Vladivostok, Russian Federation). Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases. 4333

Member's Comments

No comment yet.

Related content which might interest you: Effect of different asthma treatments on risk of cold-related exacerbations Source: Eur Respir J 2011; 38: 584-593 Year: 2011 The risk of respiratory tract infections and antibiotic use in a general population and among people with asthma Source: ERJ Open Res, 7 (4) 00429-2021; 10.1183/23120541.00429-2021 Year: 2021 Individual risks of developing chronic bronchitis and respiratory symptoms  in smokers Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021 Christmas as a risk factor for exacerbations of COPD, adult asthma and respiratory infections Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Management of lower respiratory tract infections by French general practitioners: the AIR II study Source: Eur Respir J 2002; 19: 314-319 Year: 2002 The economic burden of respiratory diseases: COPD and asthma Source: Eur Respir Monogr 2014; 65: 116-124 Year: 2014 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The impact of airway infection on cardiovascular risk during COPD exacerbations Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Malnutrition influences exacerbations and airways bacterial colonization in COPD patients with chronic respiratory failure Source: Eur Respir J 2003; 22: Suppl. 45, 540s Year: 2003 Early-life respiratory tract infections and the risk of lower lung function and asthma:a meta-analysis of 154,492 children. Source: International Congress 2017 – Determinants of childhood asthma and atopy Year: 2017 Does regular physiotherapy prevent LRTIs in patients with chronic lung disease? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity Source: Eur Respir J 2002; 20: Suppl. 38, 545s Year: 2002 Association of asthma exacerbations and upper respiratory tract infections (URTIs) Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Perennial allergy is a modifiable risk factor for exacerbations and respiratory infections in asthma patients Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases Year: 2020 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 COPD and respiratory viral infections as risk factors for the development of cardiovascular events Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Adherence rate to inhaled therapies and factors affecting adherence in elderly with chronic obstructive lung diseases Source: International Congress 2018 – Primary care management of respiratory conditions Year: 2018 Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity Source: Eur Respir J 2003; 21: 10S-14S Year: 2003